FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.55 | -31.0734463277 | 1.77 | 2 | 1.1604 | 1267921 | 1.68574437 | CS |
4 | -0.73 | -37.4358974359 | 1.95 | 2 | 1.1604 | 500456 | 1.66625397 | CS |
12 | -1.19 | -49.377593361 | 2.41 | 2.98 | 1.1604 | 252371 | 1.87437268 | CS |
26 | -0.74 | -37.7551020408 | 1.96 | 4.41 | 1.0779 | 340194 | 2.63993296 | CS |
52 | -13.47 | -91.6950306331 | 14.69 | 17.75 | 1.0779 | 243118 | 4.16640434 | CS |
156 | -28.78 | -95.9333333333 | 30 | 55 | 1.0779 | 241347 | 4.47791963 | CS |
260 | -28.78 | -95.9333333333 | 30 | 55 | 1.0779 | 241347 | 4.47791963 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions